|
0 Companies |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
1 Trial |
|
3 News |
|
- New trial: The Fibrodysplasia Ossificans Progressiva (FOP) Connection Registry (clinicaltrials.gov) - Apr 20, 2016
P=N/A, N=800, Recruiting, Sponsor: The International FOP Association
- | Biomarker, Trial completion, Enrollment change, Trial primary completion date: Urine Sample Collection From FOP Patients (clinicaltrials.gov) - Mar 12, 2015
P=N/A, N=25, Completed, Sponsor: Novartis Pharmaceuticals
Recruiting --> Completed | N=20 --> 25 | Trial primary completion date: May 2014 --> Aug 2014
- Biomarker: Urine Sample Collection From FOP Patients (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=20, Recruiting, Sponsor: Novartis Pharmaceuticals